RDY: Summary for DR. REDDY'S LAB LTD - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 12:35am EST - Canadian Markets open in 8 hours and 55 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Dr. Reddy's Laboratories Ltd. (RDY)

On Feb 9: 23.66 USD

0.32 (1.37%)

MORE ON RDY

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

DR. REDDY'S LAB LTD (NYSE:RDY) Delayed quote data

After Hours: 23.62

0.04 (0.16%) as of 4:14pm EST on 02/09/10

Last Trade:	23.66 USD
Trade Time:	Feb 9
Change:	0.32 (1.37%)
Prev Close:	23.34
Open:	23.73
Bid:	N/A
Ask:	N/A
1y Target Est:	19.00

Day's Range:	23.13 - 23.73
52wk Range:	7.27 - 27.33
Volume:	511,705
Avg Vol (3m):	445,586
Market Cap:	3.99B
P/E (ttm):	22.75
EPS (ttm):	1.04
Div & Yield:	0.13 (0.56%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add RDY to Portfolio

Download Data

HEADLINES

•	Cash In on the Plummeting Dollar With This Stock
	at Motley Fool (Fri, Feb 5)

•	Indian Markets Thursday Wrap-Up: Six Day Losing Streak Snapped
	at Seeking Alpha (Thu, Jan 28)

•	Improving Visibility on Watson
	Zacks.com (Wed, Jan 27)

•	Aegis Therapeutics and Dr. Reddy's Announce Strategic Alliance
	Marketwire (Mon, Jan 25)

•	Dr Reddy Reports, Slashes Guidance
	Zacks.com (Thu, Jan 21)

•	UPDATE - India Dr Reddy's incurs Q3 loss, cuts FY10 f'cast
	at Reuters (Wed, Jan 20)

•	Indian Markets Wednesday Wrap-Up: Earnings, Global Cues Effect Sentiment
	at Seeking Alpha (Wed, Jan 20)

•	Q3 09/2010 Dr. Reddy's Laboratories Ltd. Earnings Release - Time Not Supplied
	CCBN (Wed, Jan 20)

•	Dr. Reddy's swings to loss after write-down
	at MarketWatch (Wed, Jan 20)

•	Dr. Reddys Q3 FY10 Financial Results
	Business Wire (Wed, Jan 20)

•	India's Dr Reddy's posts $113 mln net loss in Q3
	at Reuters (Wed, Jan 20)

•	Pfizer Gets Serious About Generics
	at Motley Fool (Tue, Jan 19)

•	Dr. Reddy's downgraded by Deutsche Bank
	Briefing.com (Tue, Jan 19)

•	Indian Markets Monday Wrap-Up: Banks Drive Indicese to Strong Finish
	at Seeking Alpha (Mon, Jan 18)

•	Get Out Now!
	at Motley Fool (Fri, Jan 15)

More Headlines for RDY...

ANALYST

EPS Est (next year) (Mar-08) :	0.71
EPS Est (in 2 years) (Mar-09) :	1.11
Avg Rec (current)*:	3.0
PEG Ratio:	1.35

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as a pharmaceutical company. It focuses on formulations, active pharmaceutical ingredients and intermediates, generic drugs, critical care products, biotechnology products,...

Full Company Profile

Add to Portfolio

Email to a Friend

•